Ticker archive � $AMGN

$AMGN Filing Signals & Market Reactions

Delayed, SEO-crawlable recaps of AI-scored catalysts for $AMGN � including observed post-filing price moves. Live streaming stays exclusive to VIP.

? All delayed signals

$AMGN

$AMGN � Amgen Reports Imdelltra-Imfinzi Combo Cut Death Risk by 58% in First-Line SCLC

2026-10-24 14:38:23 UTC � TELEGRAM � All $AMGN

?? Positive AI Sentiment (+6.8 / 10)

• Nearly 80% 1-year survival rate vs 53% for monotherapy in extensive-stage small cell lung cancer. • Progression-free survival (PFS) more than tripled under combination regimen. • Represents significant clinical outperformance and commercial expansion potential for Imdelltra.

Unlock Live VIP Terminal & Telegram � �10/mo Original filing ?

$AMGN

$AMGN � Amgen's Imdelltra plus Durvalumab Extends Median Overall Survival to 21.1 Months

2026-10-24 14:38:23 UTC � TELEGRAM � All $AMGN

?? Positive AI Sentiment (+6.5 / 10)

• Imdelltra plus durvalumab extended median overall survival to 21.1 months vs 12.7 months for monotherapy • Grade 3+ adverse events reported at 20.9% for combination vs 10.8% for monotherapy • Safety profile remains consistent with known individual medicine profiles

Unlock Live VIP Terminal & Telegram � �10/mo Original filing ?